Market Overview

ATCC Introduces Innovative Depositor and Material Transfer Agreements


ATCC, the premier biological materials resource and standards organization, today announced its new depositor and material transfer agreements (MTA). Both agreements became effective March 1, 2012, according to ATCC.

“With these new agreements, we are bringing to the bioresearch community a new model for material sharing and exchange,” said ATCC President, Dr. Brian A. Pollok. “Our goal is to propel new material availability on the front end by recognizing the value provided by researchers when they deposit with ATCC, while also removing on the back end key material transfer barriers to collaboration.”

The revamped MTA provides many benefits for researchers. No prior written consent is required to transfer modifications (such as engineered cell lines) and unmodified derivatives (for example, DNA), for specific research purposes. Collaborators can access new web-based forms to populate transfers which can be completed within just 14 days. Another key enhancement is that drug screening and ADME/Tox is removed from the list of commercial uses, eliminating the need for a separate license.

ATCC Executive CEO Dr. Raymond Cypess added, “The importance of this support from ATCC can have a major impact on drug discovery. These opportunities are critical to the research community which thrives on the ability to collaborate and advance scientific endeavors through the sharing of knowledge and tools. The ability to gain insights in this way is critical for academic labs to pool resources and collaborate with other like-minded research organizations.”

ATCC exceeds the expectations of its customers with innovation and execution of assets, like the MTA, and future enhancements to products and services.


ATCC provides research and development tools and reagents as well as related biological material management services, consistent with its mission: to acquire, authenticate, preserve, develop, and distribute standard reference microorganisms, cell lines, and related materials for research in the life sciences.

For more information, visit

Dionne Dyches, 703-365-2879

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at